Selbyville, DE -- (SBWIRE) -- 11/27/2018 -- Market Study Report Adds New Extracorporeal Membrane Oxygenation Market 2018 – 2024 research report providing information By Modality (Venoarterial, Veno-venous, Arteriovenous), By Application (Cardiac, Respiratory, Extracorporeal cardiopulmonary resuscitation), By Patient Population (Infant, Paediatric, Adult)

Increase in incidences of cardiopulmonary diseases and respiratory failure in developing regions will augment the extracorporeal membrane oxygenation market growth over the forecast years. Developed countries such as Japan should also witness increasing incidences of COPD dur to rapidly increasing. Total number of people seeking treatment for respiratory disease in Japan is around 260,000. The rising number of patient will propel the ECMO marker growth in upcoming years.

Request a Sample of this premium Research Report@ https://www.marketstudyreport.com/request-a-sample/1230574/

High risks complications related to ECMO such as stroke, excessive bleeding, infection and pneumonia will be one of the major market impeding factor. According to a study conducted by National Institute for Health and Care Excellence, around 50% of the patients died during ECMO procedure due to severe bacterial infection and multiple organ failure. Aforementioned factors will play major role in restraining the industry growth.

Venoarterial (VA) ECMO market is estimated to grow with a CAGR of 4.3% during the projection years. Increasing use of Veno-arterial ECMO for resuscitating patients in cardiogenic shock will propel the segment growth. Venoarterial extracorporeal membrane oxygenation (ECMO) has to come up as perfect option to provide definitive and rapid mechanical circulation to the patients with cardiopulmonary failure or post cardiotomy patients with biventricular dysfunction.

Application of ECMO in cardiac diseases held significant market share with a total value of around USD 84.7 million 2017. According to European Heart Network, every year cardiovascular diseases account for around 4 million deaths in Europe. Increase in prevalence of cardiovascular diseases across the globe should drive the segment growth.

Infant patient population will experience lucrative growth from the year 2018 to 2024 at a robust CAGR of 3.0%. The neonatal respiratory patients have been treated most successfully with the help of ECMO. Increase in use of extracorporeal membrane oxygenation (ECMO) in infants suffering from severe cardiopulmonary failure will augment the segment growth in the near future.

Top Manufacturers in global market are given bellow: Abbott Laboratories, Alung Technologies, Braile Biomedical, Edwards Lifesciences Corp, Elsius Biomedical Inc., Eurosets Srl, Getinge Group, LivaNova PLC, Medtronic Inc., MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Spectrum Medical, Terumo Corporation

Request a Discount on standard prices of this premium Market Research Report@ https://www.marketstudyreport.com/check-for-discount/1230574/

China extracorporeal membrane oxygenation market was valued over USD 13.7 million in the year 2017. According to the World Health Organization (WHO), China is facing an increasing epidemic of cardiovascular diseases with around 230 million people suffering from it. Rise in incidence of respiratory disorders among the people due to several environmental factors will fuel the regional industry growth in the upcoming years.

The above information is provided on a regional and country basis for the following:
U.S., Canada, Germany, UK, Italy, France, Spain, China, India, Japan, Taiwan, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa,, Kuwait

By Modality
- Venoarterial
- Veno-venous
- Arteriovenous

By Application
- Cardiac
- Respiratory
- Extracorporeal cardiopulmonary resuscitation

By Patient Population
- Infant
- Paediatric
- Adult

To View Full Report@ https://www.marketstudyreport.com/reports/extracorporeal-membrane-oxygenation-market

About Market Study Report
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.